Associations between affective/vegetative neuropsychiatric symptoms and brain morphology in aging people with mild cognitive impairment and Alzheimer’s disease

Adriana Cannizzaro; Lucas Ronat; Lyna Mariam El Haffaf; Alexandru Hanganu; the ADNI

doi:10.1101/2022.10.05.22280745

Abstract

Objectives Neuropsychiatric symptoms (NPS) are common in mild cognitive impairment (MCI) and even more so in Alzheimer’s disease (AD). The affective/vegetative NPS cluster model (sleep disorders, depression, appetite changes, anxiety, and apathy) has been associated with an increased risk of dementia in patients with MCI and these five NPS have common neuroanatomical associations. Hence, in this study, we examined how brain morphology is influenced by the severity of affective/vegetative NPS across different stages of cognitive performance.

Participants 175 AD, 367 MCI and 223 cognitively normal (CN) participants.

Setting Participants were recruited at multiple centers in North America included in the ADNI project.

Design A GLM was established to test for intergroup differences (CN -MCI, CN-AD, AD-MCI) of the effects of the five NPS on brain structures. A regression model was also performed to show slope directionality of the regions of interest as NPS severity increases.

Measurements 3T MRI data (cortical volumes, areas and thickness) and severity scores of the five NPS.

Results Associations within AD were predominantly stronger compared to MCI. Increased severity of sleep disorders and appetite changes were associated with a decrease in frontal surface areas in AD. Furthermore, increased severity of all NPS (except apathy) were associated with changes in the temporal regions, predominantly with decreased volumes and surface areas.

Conclusion These findings show the implication of fronto-temporal regions with sleep disorders, depression and appetite changes, and contribute to a better understanding of brain morphological differences between CN, MCI and AD with respect to all five NPS.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by a doctoral research scholarship Centre de recherche de l'Institut Universitaire de Geriatrie de Montreal (CRIUGM)- Volet B in collaboration with NiEmoLab and a Faculty of Medicine of the University of Montreal merit scholarship given to Lucas Ronat, a doctoral research scholarship Centre de Recherche de l'Institut Universitaire de Geriatrie Montreal (CRIUGM)-Volet B in collaboration with NiEmoLab and a research bursary from NiEmoLab given to Lyna Mariam El Haffaf, as well as funding from the Parkinson Canada-Parkinson Quebec (2018-00355); IUGM Foundation; Fonds de Recherche du Quebec Sante; Lemaire Foundation given to Alexandru Hanganu

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee approval and individual patient consents were received by the corresponding registration sites according to ADNI rules (http://adni.loni.usc.edu/methods/documents/). This study was approved by the Comite d'ethique de la recherche vieillissement-neuroimagerie CER VN 19-20-06.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

↵* Alzheimer’s Disease Neuroimaging Initiative
Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in the analyses or writing of this report. A complete listing of ADNI investigators can be found at: https://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf

Data Availability

All data are available on the ADNI website upon demand (http://adni.loni.usc.edu/data-samples/access-data/).

Abbreviations

ADNI: Alzheimer’s Disease Neuroimaging Initiative
MCI: Mild Cognitive Impairment
CN: Cognitively Normal
NPI: Neuropsychiatric Inventory
NPS: Neuropsychiatric Symptoms
GLM: General Linear Model

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.